Form 1 CTG Survey

OMB No.: 0925-0648
Expiration Date: 06/30/2024

Public reporting burden for this collection of information is estimated to average 3 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to: NIH Project Clearance Branch, 6705 Rockledge Drive, MSC 7974, Bethesda, MD 20892-7974. ATTN: PRA (0925-0648). Do not return the completed form to this address.

Thank you for registering for the 2023 ClinicalTrials.gov Modernization Virtual Public Meeting taking place on Tuesday, April 25 at 12:30 p.m. ET.

In preparation for the virtual meeting, the National Library of Medicine would like to learn about your interaction with the ClinicalTrials.gov modernization effort. Please feel free to answer the questions below.

1. Have you visited the ClinicalTrials.gov Beta public website?
   (dropdown list)

• Yes

• No (skip to question 2)

1a. Did you use a mobile phone or tablet?
(dropdown list)

• Yes

• No

1b. How does the beta site compare to the classic site?
(dropdown list)

• Much better

• Somewhat better

• About the same

• Somewhat worse

• Much worse

2. If you are a Data Submitter, have you used the Protocol Registration and Results System (PRS) Beta?
   (dropdown list)

• Yes

• No

2a. How does the beta site compare to the classic site?
(dropdown list)

• Much better

• Somewhat better

• About the same

• Somewhat worse

• Much worse

3. If you have used one or both of the beta sites, please provide examples of how the site has performed in meeting your needs. What features stand out the most?

(Character limit: 500)

4. Do you have any feedback on the ClinicalTrials.gov modernization effort or the beta sites?

(Character limit: 500)

5. Participant Type (select the one that fits best)
   (dropdown list)

• Researcher

• Student

• Patient, family, caregiver, friend

• Librarian or information professional

• Educator/trainer

• Health care professional

• Journal editor or manager

• Other (please specify)

Please specify if Other was selected

6. 

   (Character limit: 500)

   What questions do you have about the ClinicalTrials.gov modernization effort or the beta sites that you would like answered during the public meeting?

*Indicates required fields

Thank you!